Altered Gastric Microbiota and Inflammatory Cytokine Responses in Patients with Helicobacter pylori-Negative Gastric Cancer

The role of the gastric mucosal microbiome in Helicobacter pylori-negative gastric cancer (GC) remains unclear. Therefore, we aimed to characterize the microbial alterations and host inflammatory cytokine responses in H. pylori-negative GC. Gastric mucosal samples were obtained from 137 H. pylori-negative patients with GC (n = 45) and controls (chronic gastritis or intestinal metaplasia, n = 92). We performed 16S rRNA gene sequencing (n = 67), a quantitative reverse transcription-polymerase chain reaction to determine the relative mRNA expression levels of TNF (tumor necrosis factor), IL1B (interleukin 1 beta), IL6 (interleukin 6), CXCL8 (C-X-C motif chemokine ligand 8), IL10 (interleukin 10), IL17A (interleukin 17A), TGFB1 (transforming growth factor beta 1) (n = 113), and the correlation analysis between sequencing and expression data (n = 47). Gastric mucosal microbiota in patients with GC showed reduced diversity and a significantly different composition compared to that of the controls. Lacticaseibacillus was significantly enriched, while Haemophilus and Campylobacter were depleted in the cancer group compared to the control group. These taxa could distinguish the two groups in a random forest algorithm. Moreover, the combined relative abundance of these taxa, a GC microbiome index, significantly correlated with gastric mucosal IL1B expression, which was elevated in the cancer group. Overall, altered gastric mucosal microbiota was found to be associated with increased mucosal IL1B expression in H. pylori-negative GC.

[1]  Yoon Kim,et al.  Dysbiotic change in gastric microbiome and its functional implication in gastric carcinogenesis , 2022, Scientific Reports.

[2]  Linlin Lu,et al.  Overgrowth of Lactobacillus in gastric cancer , 2021, World journal of gastrointestinal oncology.

[3]  Xuefeng Gao,et al.  Salivary Microbiota for Gastric Cancer Prediction: An Exploratory Study , 2021, Frontiers in Cellular and Infection Microbiology.

[4]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[5]  Jonathan P. Jacobs,et al.  Specimen Collection and Analysis of the Duodenal Microbiome. , 2021, Journal of visualized experiments : JoVE.

[6]  N. Chalasani,et al.  Effects of Rare Microbiome Taxa Filtering on Statistical Analysis , 2021, Frontiers in Microbiology.

[7]  Nayoung Kim,et al.  Helicobacter pylori Eradication Induced Constant Decrease in Interleukin-1B Expression over More Than 5 Years in Patients with Gastric Cancer and Dysplasia , 2020, Gut and liver.

[8]  Xuefeng Gao,et al.  Changes of the Gastric Mucosal Microbiome Associated With Histological Stages of Gastric Carcinogenesis , 2020, Frontiers in Microbiology.

[9]  Fen Wu,et al.  The role of gastric microbiota in gastric cancer , 2020, Gut microbes.

[10]  P. Moayyedi,et al.  Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis , 2020, Gut.

[11]  N. Ajami,et al.  Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions , 2020, Alimentary pharmacology & therapeutics.

[12]  D. Graham,et al.  Microbiome and Gastric Cancer , 2020, Digestive Diseases and Sciences.

[13]  Jun Yu,et al.  Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication , 2020, Gut.

[14]  Jianguo Xia,et al.  Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data , 2020, Nature Protocols.

[15]  C. Desterke,et al.  Gastric IL-1β, IL-8, and IL-17A expression in Moroccan patients infected with Helicobacter pylori may be a predictive signature of severe pathological stages. , 2019, Cytokine.

[16]  M. Gail,et al.  Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial , 2019, BMJ.

[17]  N. Kaakoush,et al.  Microbial carcinogenesis: Lactic acid bacteria in gastric cancer. , 2019, Biochimica et biophysica acta. Reviews on cancer.

[18]  Oliver Neubauer,et al.  Effects of dietary nitrate on inflammation and immune function, and implications for cardiovascular health. , 2019, Nutrition reviews.

[19]  E. Chuang,et al.  Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease , 2019, Journal of Neuroinflammation.

[20]  Sang Kil Lee,et al.  Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing , 2018, Helicobacter.

[21]  Fang Liu,et al.  The Clinical Importance of Campylobacter concisus and Other Human Hosted Campylobacter Species , 2018, Front. Cell. Infect. Microbiol..

[22]  I. Choi,et al.  Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer , 2018, The New England journal of medicine.

[23]  J. L. Costa,et al.  Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota , 2017, Gut.

[24]  K. Goh,et al.  Dysbiosis of the microbiome in gastric carcinogenesis , 2017, Scientific Reports.

[25]  Jun Yu,et al.  Mucosal microbiome dysbiosis in gastric carcinogenesis , 2017, Gut.

[26]  P. Sham,et al.  Alterations in Gastric Microbiota After H. Pylori Eradication and in Different Histological Stages of Gastric Carcinogenesis , 2017, Scientific Reports.

[27]  Young-Seok Cho,et al.  Korean Society of Gastrointestinal Endoscopy Guidelines for Endoscope Reprocessing , 2017, Clinical endoscopy.

[28]  K. Matusiewicz,et al.  Campylobacter concisus as the etiologic agent of gastrointestinal diseases. , 2017, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[29]  C. Huttenhower,et al.  Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity , 2016, Cell.

[30]  Nayoung Kim,et al.  An Appropriate Cutoff Value for Determining the Colonization of Helicobacter pylori by the Pyrosequencing Method: Comparison with Conventional Methods , 2015, Helicobacter.

[31]  K. Song,et al.  Differences in Gastric Mucosal Microbiota Profiling in Patients with Chronic Gastritis, Intestinal Metaplasia, and Gastric Cancer Using Pyrosequencing Methods , 2014, Helicobacter.

[32]  F. Avilés-Jiménez,et al.  Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer , 2014, Scientific Reports.

[33]  G. Macfarlane,et al.  Oesophageal bacterial biofilm changes in gastro‐oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality? , 2013, Alimentary pharmacology & therapeutics.

[34]  E. Gamazon,et al.  Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis , 2013, Gut.

[35]  C. Eom,et al.  Lactobacillus casei Extract Induces Apoptosis in Gastric Cancer by Inhibiting NF-κB and mTOR-Mediated Signaling , 2013, Integrative cancer therapies.

[36]  A. Neish,et al.  Reactive oxygen production induced by the gut microbiota: pharmacotherapeutic implications. , 2012, Current medicinal chemistry.

[37]  T. Ushijima,et al.  Molecular Pathways Molecular Pathways : Involvement of Helicobacter pylori – Triggered In fl ammation in the Formation of an Epigenetic Field Defect , and Its Usefulness as Cancer Risk and Exposure Markers , 2012 .

[38]  Kazuo Hase,et al.  Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes? , 2010, Gastric Cancer.

[39]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.